Stockscreener 앱 받기
11.25
9.71%
-1.21
시간 외 거래:
11.43
0.18
+1.60%
전일 마감가:
$12.46
열려 있는:
$12.07
하루 거래량:
1.82M
Relative Volume:
0.94
시가총액:
$1.01B
수익:
$139.71M
순이익/손실:
$-209.36M
주가수익비율:
-3.8007
EPS:
-2.96
순현금흐름:
$-160.60M
1주 성능:
-14.64%
1개월 성능:
-21.77%
6개월 성능:
-40.22%
1년 성능:
-50.27%
1일 변동 폭
$11.09
$12.17
1주일 범위
$11.09
$13.01
52주 변동 폭
$11.09
$25.07
Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile
명칭
Syndax Pharmaceuticals Inc
전화
781-419-1400
주소
35 GATEHOUSE DRIVE, WALTHAM, MA
SNDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNDX
Syndax Pharmaceuticals Inc
|
11.25 | 1.01B | 139.71M | -209.36M | -160.60M | -2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 65.79B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 35.18B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 32.67B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 26.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-06-28 | 개시 | Jefferies | Buy |
| 2024-01-31 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2023-12-22 | 개시 | Mizuho | Buy |
| 2023-10-25 | 개시 | BofA Securities | Buy |
| 2023-10-11 | 개시 | Goldman | Buy |
| 2023-07-27 | 개시 | Scotiabank | Sector Outperform |
| 2023-07-11 | 개시 | Guggenheim | Buy |
| 2023-04-17 | 재개 | BTIG Research | Buy |
| 2023-01-31 | 개시 | Stifel | Buy |
| 2023-01-03 | 개시 | JP Morgan | Overweight |
| 2022-07-28 | 재개 | B. Riley Securities | Buy |
| 2022-04-11 | 개시 | H.C. Wainwright | Buy |
| 2022-02-15 | 개시 | Goldman | Buy |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2021-05-25 | 개시 | Citigroup | Buy |
| 2021-02-18 | 개시 | B. Riley Securities | Buy |
| 2020-12-03 | 개시 | Stifel | Buy |
| 2020-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-05-22 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-05-18 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-05-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-04 | 개시 | Barclays | Overweight |
| 2020-01-13 | 재확인 | H.C. Wainwright | Buy |
| 2019-03-08 | 재확인 | H.C. Wainwright | Buy |
| 2019-01-04 | 개시 | Robert W. Baird | Outperform |
| 2018-01-05 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-03-16 | 개시 | FBR & Co. | Outperform |
| 2017-03-02 | 개시 | Instinet | Buy |
| 2016-10-07 | 개시 | Guggenheim | Buy |
| 2016-03-28 | 개시 | Citigroup | Buy |
| 2016-03-28 | 개시 | JMP Securities | Mkt Outperform |
| 2016-03-28 | 개시 | Morgan Stanley | Overweight |
모두보기
Syndax Pharmaceuticals Inc 주식(SNDX)의 최신 뉴스
Syndax Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Up 4.7%Here's Why - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Trading Down 7.5%Should You Sell? - MarketBeat
Axiom Investors LLC DE Sells 62,418 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Raised to Sell at StockNews.com - MarketBeat
How the (SNDX) price action is used to our Advantage - news.stocktradersdaily.com
Syndax Pharmaceuticals (NASDAQ:SNDX) Sets New 1-Year LowHere's What Happened - MarketBeat
Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum - The Manila Times
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Purchased by Teacher Retirement System of Texas - Defense World
Syndax stock touches 52-week low at $12.05 amid market challenges - Investing.com
Simplify Asset Management Inc. Purchases 25,456 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
What Do Analysts Think About Syndax Pharmaceuticals Inc’s (NASDAQ:SNDX) Future? - Stocks Register
Syndax Pharmaceuticals (NASDAQ:SNDX) Given New $41.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Up 5.5% Following Analyst Upgrade - MarketBeat
Long Term Trading Analysis for (SNDX) - news.stocktradersdaily.com
Charles Schwab Investment Management Inc. Purchases 8,876 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Raised to $41.00 - Defense World
Syndax Pharmaceuticals’ 41% decline validates InvestingPro’s bearish call By Investing.com - Investing.com UK
Syndax's Revuforj Earns Strong Physician Support, JP Morgan Predicts Sales Growth - Benzinga
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Up 5.5% on Analyst Upgrade - Defense World
Bank of New York Mellon Corp Increases Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
US Bancorp DE Reduces Stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives $36.00 Average Price Target from Analysts - MarketBeat
Syndax at Barclays Healthcare Conference: Strategic Vision for Menin Inhibitors - Investing.com UK
Syndax Pharmaceuticals’ SWOT analysis: stock soars on FDA approvals, faces profitability hurdles By Investing.com - Investing.com South Africa
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Syndax Pharmaceuticals’ SWOT analysis: stock soars on FDA approvals, faces profitability hurdles - Investing.com India
Graft Versus Host Disease Market Expected to rise, 2034 | Biocon, medac GmbH, MaaT Pharma, ElsaLys Biotech, Glia, Syndax Pharmaceuticals, ASC Therapeutics, SCM Lifescience, REGiMMUNE, Roche, VectivBio - The Globe and Mail
Candriam S.C.A. Cuts Stock Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat
What Does Syndax Pharmaceuticals Inc’s (NASDAQ: SNDX) Future Hold? - Stocks Register
What is B. Riley's Forecast for SNDX Q3 Earnings? - MarketBeat
What is HC Wainwright's Forecast for SNDX FY2025 Earnings? - MarketBeat
What is HC Wainwright's Forecast for SNDX Q1 Earnings? - MarketBeat
Q1 Earnings Forecast for SNDX Issued By B. Riley - MarketBeat
Syndax Pharmaceuticals (NASDAQ:SNDX) Trading Down 7.4% Following Weak Earnings - MarketBeat
JPMorgan Chase & Co. Issues Positive Forecast for Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price - MarketBeat
Citigroup Issues Pessimistic Forecast for Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price - MarketBeat
Syndax Pharmaceuticals' (SNDX) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
Syndax Pharmaceuticals Reports 2024 Financial Results - MSN
Syndax Pharmaceuticals Inc to Host Earnings Call - ACCESS Newswire
What is B. Riley’s Estimate for SNDX Q3 Earnings? - Defense World
What is HC Wainwright’s Forecast for SNDX FY2025 Earnings? - Defense World
Syndax Pharmaceuticals Inc (SNDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10.70%
자본화:
|
볼륨(24시간):